Stein, Jeffrey S. http://orcid.org/0000-0001-5251-3447
Craft, William H.
Paluch, Rocco A.
Gatchalian, Kirstin M.
Greenawald, Mark H.
Quattrin, Teresa
Mastrandrea, Lucy D.
Epstein, Leonard H.
Bickel, Warren K.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1UH2DK109543)
Article History
Received: 24 February 2020
Accepted: 2 September 2020
First Online: 28 September 2020
Compliance with ethical standards
:
: Although the following activities/relationships do not create conflict of interests pertaining to this manuscript, in the interest of full disclosure, we would like to report the following: Warren K. Bickel is a principal of HealthSim, LLC; Notifius, LLC; BEAM Diagnostics, Inc.; and a partner for Red 5 Group, LLC. In addition, he serves on the scientific advisory board for Sober Grid, Inc.; Ria Health; US WorldMeds, LLC; and is a consultant for Alkermes, Inc. and Nektar Therapeutics. Dr. Mastrandrea received research funding from the Juvenile Diabetes Research Foundation, NovoNordisk, Sanofi Aventis, and AstraZeneca. The other authors do not declare any conflict of interest with respect to the authorship or publication of this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study and all study procedures were approved by the University at Buffalo Institutional Review Boards.